Nephro-Urology Monthly

Published by: Kowsar

Effect of Testosterone on Cisplatin-Induced Nephrotoxicity in Surgically Castrated Rats

Bahar Rostami 1 , Mehdi Nematbakhsh 1 , 2 , 3 , * , Zahra Pezeshki 1 , Ardeshir Talebi 1 , 4 , Mohammad Reza Sharifi 2 , Fatemeh Moslemi 1 , Fatemeh Eshraghi-Jazi 1 and Farzaneh Ashrafi 1
Authors Information
1 Water and Electrolytes Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
2 Department of Physiology, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Institute of Basic and Applied Sciences Research, Isfahan, IR Iran
4 Department of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Nephro-Urology Monthly: September 01, 2014, 6 (5); e21546
  • Published Online: September 5, 2014
  • Article Type: Research Article
  • Received: June 28, 2014
  • Revised: July 7, 2014
  • Accepted: July 10, 2014
  • DOI: 10.5812/numonthly.21546

To Cite: Rostami B, Nematbakhsh M, Pezeshki Z, Talebi A, Sharifi M R, et al. Effect of Testosterone on Cisplatin-Induced Nephrotoxicity in Surgically Castrated Rats, Nephro-Urol Mon. 2014 ; 6(5):e21546. doi: 10.5812/numonthly.21546.

Copyright © 2014, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol. 2003; 23(5): 460-4[PubMed]
  • 2. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel). 2010; 2(11): 2490-518[DOI][PubMed]
  • 3. Davis CA, Nick HS, Agarwal A. Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol. 2001; 12(12): 2683-90[PubMed]
  • 4. Luke DR, Vadiei K, Lopez-Berestein G. Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant. 1992; 7(1): 1-7[PubMed]
  • 5. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 2002; 110(6): 835-42[DOI][PubMed]
  • 6. Winston JA, Safirstein R. Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol. 1985; 249(4 Pt 2)-6[PubMed]
  • 7. Appenroth D, Frob S, Kersten L, Splinter FK, Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997; 71(11): 677-83[PubMed]
  • 8. Bagnis C, Beaufils H, Jacquiaud C, Adabra Y, Jouanneau C, Le Nahour G, et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant. 2001; 16(5): 932-8[PubMed]
  • 9. Eshraghi-Jazi F, Nematbakhsh M, Nasri H, Talebi A, Haghighi M, Pezeshki Z, et al. The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model. J Res Med Sci. 2011; 16(11): 1389-96[PubMed]
  • 10. Mohamed HE, El-Swefy SE, Mohamed RH, Ghanim AM. Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats. Exp Toxicol Pathol. 2013; 65(1-2): 197-203[DOI][PubMed]
  • 11. Saleh S, Ain-Shoka AA, El-Demerdash E, Khalef MM. Protective effects of the angiotensin II receptor blocker losartan on cisplatin-induced kidney injury. Chemotherapy. 2009; 55(6): 399-406[DOI][PubMed]
  • 12. Nematbakhsh M, Ashrafi F, Safari T, Talebi A, Nasri H, Mortazavi M, et al. Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats. J Nephrol. 2012; 25(3): 410-7[DOI][PubMed]
  • 13. Soltani N, Nematbakhsh M, Eshraghi-Jazi F, Talebi A, Ashrafi F. Effect of oral administration of magnesium on Cisplatin-induced nephrotoxicity in normal and streptozocin-induced diabetic rats. Nephrourol Mon. 2013; 5(4): 884-90[DOI][PubMed]
  • 14. Saadat A, Shariat Maghani SS, Rostami Z, Davoudi A, Davoudi F, Shafie A, et al. Normobaric hyperoxia preconditioning ameliorates cisplatin nephrotoxicity. Ren Fail. 2014; 36(1): 5-8[DOI][PubMed]
  • 15. Nematbakhsh M , Talebi A , Nasri H , Safari T , et al . Some evidence for sex-based differences in cisplatin-induced nephrotoxicity in rats. Clin Exp Med Lett. 2012; 53(1-2): 29-32
  • 16. Nematbakhsh M, Ebrahimian S, Tooyserkani M, Eshraghi-Jazi F, Talebi A, Ashrafi F. Gender difference in Cisplatin-induced nephrotoxicity in a rat model: greater intensity of damage in male than female. Nephrourol Mon. 2013; 5(3): 818-21[DOI][PubMed]
  • 17. Pezeshki Z, Nematbakhsh M, Nasri H, Talebi A, Pilehvarian AA, Safari T, et al. Evidence against protective role of sex hormone estrogen in Cisplatin-induced nephrotoxicity in ovarectomized rat model. Toxicol Int. 2013; 20(1): 43-7[DOI][PubMed]
  • 18. Lu Y, Fu Y, Ge Y, Juncos LA, Reckelhoff JF, Liu R. The vasodilatory effect of testosterone on renal afferent arterioles. Gend Med. 2012; 9(2): 103-11[DOI][PubMed]
  • 19. Kim J, Kil IS, Seok YM, Yang ES, Kim DK, Lim DG, et al. Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice. A role for manganese superoxide dismutase. J Biol Chem. 2006; 281(29): 20349-56[DOI][PubMed]
  • 20. Soljancic A, Ruiz AL, Chandrashekar K, Maranon R, Liu R, Reckelhoff JF, et al. Protective role of testosterone in ischemia-reperfusion-induced acute kidney injury. Am J Physiol Regul Integr Comp Physiol. 2013; 304(11)-8[DOI][PubMed]
  • 21. Ammer U, Natochin Y, David C, Rumrich G, Ullrich KJ. Cisplatin nephrotoxicity: site of functional disturbance and correlation to loss of body weight. Ren Physiol Biochem. 1993; 16(3): 131-45[PubMed]
  • 22. Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin c against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res. 2000; 41(4): 405-11[DOI][PubMed]
  • 23. Deegan PM, Nolan C, Ryan MP, Basinger MA, Jones MM, Hande KR. The role of the renin-angiotensin system in cisplatin nephrotoxicity. Ren Fail. 1995; 17(6): 665-74[PubMed]
  • 24. Saad SY, Najjar TA, Daba MH, Al-Rikabi AC. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine. Chemotherapy 2002; 48(6): 309-15[PubMed]
  • 25. Saleh S, El-Demerdash E. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide. Basic Clin Pharmacol Toxicol. 2005; 97(2): 91-7[DOI][PubMed]
  • 26. Stakisaitis D, Dudeniene G, Jankunas RJ, Grazeliene G, Didziapetriene J, Pundziene B. Cisplatin increases urinary sodium excretion in rats: gender-related differences. Medicina (Kaunas). 2010; 46(1): 45-50[PubMed]
  • 27. Pezeshki Z, Nematbakhsh M, Mazaheri S, Eshraghi-Jazi F, Talebi A, Nasri H, et al. Estrogen Abolishes Protective Effect of Erythropoietin against Cisplatin-Induced Nephrotoxicity in Ovariectomized Rats. ISRN Oncol. 2012; 2012: 890310[DOI][PubMed]
  • 28. Nematbakhsh M, Pezeshki Z, Eshraghi-Jazi F, Ashrafi F, Nasri H, Talebi A, et al. Vitamin E, Vitamin C, or losartan is not nephroprotectant against cisplatin-induced nephrotoxicity in presence of estrogen in ovariectomized rat model. Int J Nephrol 2012; 2012: 284896
  • 29. Ali BH, Al Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol. 2006; 44(8): 1173-83[DOI][PubMed]
  • 30. Maheshwari RA, Sailor GU, Patel L, Balaraman R. Amelioration of cisplatin-induced nephrotoxicity by statins. Indian J Pharmacol. 2013; 45(4): 354-8[DOI][PubMed]
  • 31. Maines MD, Sluss PM, Iscan M. cis-platinum-mediated decrease in serum testosterone is associated with depression of luteinizing hormone receptors and cytochrome P-450scc in rat testis. Endocrinology. 1990; 126(5): 2398-406[DOI][PubMed]
  • 32. Allan CA, McLachlan RI. Androgens and obesity. Curr Opin Endocrinol Diabetes Obes. 2010; 17(3): 224-32[DOI][PubMed]
  • 33. Iglesias P, Carrero JJ, Diez JJ. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol. 2012; 25(1): 31-42[DOI][PubMed]
  • 34. Malkin CJ, Pugh PJ, Morris PD, Asif S, Jones TH, Channer KS. Low serum testosterone and increased mortality in men with coronary heart disease. Heart. 2010; 96(22): 1821-5[DOI][PubMed]
  • 35. Rao SR, Kini S, Tamler R. Sex hormones and bariatric surgery in men. Gend Med. 2011; 8(5): 300-11[DOI][PubMed]
  • 36. Saad F. Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease? Diabetes Metab Res Rev. 2012; 28 Suppl 2: 52-9[DOI][PubMed]
  • 37. Kyriazis J, Tzanakis I, Stylianou K, Katsipi I, Moisiadis D, Papadaki A, et al. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients. Nephrol Dial Transplant. 2011; 26(9): 2971-7[DOI][PubMed]
  • 38. Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, et al. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol. 2011; 6(7): 1617-25[DOI][PubMed]
  • 39. Carrero JJ, Barany P, Yilmaz MI, Qureshi AR, Sonmez A, Heimburger O, et al. Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease. Nephrol Dial Transplant. 2012; 27(2): 709-15[DOI][PubMed]
  • 40. Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem. 2004; 279(50): 52282-92[DOI][PubMed]
  • 41. Verzola D, Gandolfo MT, Salvatore F, Villaggio B, Gianiorio F, Traverso P, et al. Testosterone promotes apoptotic damage in human renal tubular cells. Kidney Int. 2004; 65(4): 1252-61[DOI][PubMed]
  • 42. Sadowska-Krepa E, Klapcinska B, Jagsz S, Sobczak A, Chrapusta SJ, Chalimoniuk M, et al. High-dose testosterone propionate treatment reverses the effects of endurance training on myocardial antioxidant defenses in adolescent male rats. Cardiovasc Toxicol. 2011; 11(2): 118-27[DOI][PubMed]
  • 43. Saad F, Haider A, Doros G, Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity (Silver Spring). 2013; 21(10): 1975-81[DOI][PubMed]
  • 44. Mooradian AD. Antioxidant properties of steroids. J Steroid Biochem Mol Biol. 1993; 45(6): 509-11[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments